Overall Score

Valuation

Shares trade at a modest valuation with P/E of 12.2x, P/B of 1.03x, and price-to-sales of 2.34x.

Free cash flow yield is solid at 11.3%, supporting a reasonable cash-return profile.

EV/EBITDA remains elevated at 35.5x, limiting upside on an enterprise basis.

Financial Health

Liquidity remains very tight with a current ratio of 0.15x and quick ratio of 0.15x.

Leverage is high, with debt-to-equity at 1.17x and net debt-to-EBITDA at 17.7x.

Cash generation is weak relative to obligations, as operating cash flow ratio is only 0.02x and interest coverage is 0.35x.

Profitability

Margins are healthy, with gross margin at 65.4% and net margin at 18.6%.

Returns are modest, including ROE of 8.6% and ROIC of 1.9%.

Asset efficiency is low, with asset turnover at 0.07x despite strong fixed-asset turnover.

Cash Flow

Free cash flow conversion is strong, with free cash flow to operating cash flow at 95.6%.

FCF yield is attractive at 11.3%, and price-to-FCF is 8.8x.

Capital spending remains light at 1.2% of revenue, supporting cash generation.

Balance Sheet

Working capital is deeply negative at -$1.56B, and net current asset value is also negative.

Cash and liquidity buffers are thin relative to short-term needs, with cash ratio at 0.02x.

Debt load remains heavy versus market value, with debt-to-market-cap at 1.09x.